- As China gears up for a reopening from zero-Covid, this is how five startups claimed they did in 2022.
Check out the companies making headlines before the bell. Moderna — The biotechnology firm’s stock rose nearly 11% after it said it agreed to pay up to $2.25 billion to settle with Biopharma Corporation and Genevant Sciences GmbH a lawsuit over a Covid vaccine patent dispute. Ross Stores — Shares popped 7% after the off-price […]
Read More
Key Points Beijing is expected to set GDP growth target at around 4.5% to 5% this year, inflation target unchanged at 2%, budget deficit of 4%. The world’s second-largest economy faces persistent challenges at home amid a consumption downturn and prolonged real estate slump. Source
Read More
Investors are wondering if buying the dip when war breaks out will work this time around as the conflict between the U.S. and Iran grows. The old Wall Street adage “buy the cannons, sell the trumpets” suggests that traders might race to pick up stocks in reaction to war headlines, expecting a rebound. But the […]
Read More